(Bloomberg) -- Speculation that Apple Inc. is seeking a partner to develop its own electric vehicle swept through South Korea and Japan, where shares of major car companies climbed on reports of discussions with the maker of the iPhone.Kia Motors Corp. is talking to potential partners about a plan to assemble an Apple-designed car, the Wall Street Journal reported Friday. … [Read more...] about Apple Car Reports Fuel Speculation of Kia or Japan Carmaker Deal
Finanace
Fuel-Cell Truck Startup Hyzon Agrees to Merge With Decarbonization Plus SPAC
TipRanksThe 5G Revolution Could Send These 3 Stocks HigherWe’ve got a full month of 2021 behind us now, and a few trends are coming clearer. The coronavirus crisis may still be with us, but as vaccination programs expand, the end is in sight. With President Trump out of the picture, and the Democrats holding both Houses of Congress and the White House, politics is looking more … [Read more...] about Fuel-Cell Truck Startup Hyzon Agrees to Merge With Decarbonization Plus SPAC
Robinhood Removes Limits on Buying GameStop, AMC Entertainment
Robinhood Removes Limits on Buying GameStop, AMC Entertainment … [Read more...] about Robinhood Removes Limits on Buying GameStop, AMC Entertainment
Alibaba’s $38 Billion Bond Sale Shows Jack Ma Fans Still Believe
(Bloomberg) -- Alibaba Group Holding Ltd. drew robust orders for a $5 billion bond sale, demonstrating investor confidence in the e-commerce giant’s long-term prospects amid easing tensions with Chinese regulators.The four-tranche offer received more than $38 billion in orders at the peak, according to people with knowledge of the matter. The notes comprising 10-year, 20-year, … [Read more...] about Alibaba’s $38 Billion Bond Sale Shows Jack Ma Fans Still Believe
MannKind Stock Is up 60% in One Month; Is There Room for More Upside?
TipRanksThe 5G Revolution Could Send These 3 Stocks HigherWe’ve got a full month of 2021 behind us now, and a few trends are coming clearer. The coronavirus crisis may still be with us, but as vaccination programs expand, the end is in sight. With President Trump out of the picture, and the Democrats holding both Houses of Congress and the White House, politics is looking more … [Read more...] about MannKind Stock Is up 60% in One Month; Is There Room for More Upside?
Kuaishou Nearly Triples In Biggest Internet IPO Since Uber
Kuaishou Nearly Triples In Biggest Internet IPO Since Uber … [Read more...] about Kuaishou Nearly Triples In Biggest Internet IPO Since Uber
Gilead Expects Covid Treatment Remdesivir Is Needed for Another Year
Text size Boxes of Remdisivir anti-viral drug Sima Diab/Bloomberg Last month, Gilead Sciences alerted investors that its December 2020 quarter had been good. On Thursday, the drug maker (ticker: GILD) reported the … [Read more...] about Gilead Expects Covid Treatment Remdesivir Is Needed for Another Year
Pinterest adds 100 million users in 2020, Q4 revenue surges 76%
Pinterest Inc. capped off a roaring 2020 by adding a record 100 million-plus users for the year and posting 76% year-over-year growth in fourth-quarter revenue on the strength of holiday retail, the company said Thursday. Pinterest PINS, +0.91% shares rose sharply, as high as 10% after hours, after rising 0.9% in the regular session to close at $77.85. … [Read more...] about Pinterest adds 100 million users in 2020, Q4 revenue surges 76%
The worst ways people will use the next stimulus check, according to Suze Orman
The worst ways people will use the next stimulus check, according to Suze OrmanPresident Joe Biden’s plan to give Americans a third round of stimulus checks — for as much as $1,400 — is now in the hands of Congress, and you could see additional money before spring.Personal finance icon Suze Orman wants you to start thinking now about what you'd do with new COVID relief cash. … [Read more...] about The worst ways people will use the next stimulus check, according to Suze Orman
Gilead stock rallies as it reports $1.9 billion in sales for its COVID-19 drug in Q4
Shares of Gilead Sciences Inc.’s stock gained 2.1% in after-hours trading on Thursday after the drug maker surprised investors with better-than-expected sales of its COVID-19 drug Veklury during the fourth quarter of 2020. The antiviral COVID-19 treatment, which was called remdesivir until it received a full approval from the Food and Drug Administration in October, generated … [Read more...] about Gilead stock rallies as it reports $1.9 billion in sales for its COVID-19 drug in Q4